Mindblown: a blog about philosophy.
-
2020-09-15 MACD(12, 26, 9) Bull Crossover Stocks: EAF, FLEX, LAC, MRNA, TEVA, TJX
NYSE: EAF (GrafTech International Ltd. (EAF)) NYSE: EAF (GrafTech International Ltd. (EAF)) has closed at $6.955, its traded Volume was 2807.86K shares, EAF opened the Day at $6.97, it made an intraday Low of $6.91, and an intraday High of $7.2. EAF (GrafTech International Ltd. (EAF)) 52-week High is $14.84, 52-week Low is: $5.56, it…
-
2020-09-15 MA5-MA15 Bull Crossover Stock: HZNP, KPTI, LAC, LLY, NEE, TSM
NASDAQ: HZNP (Horizon Therapeutics Public Limited Company (HZNP)) NASDAQ: HZNP (Horizon Therapeutics Public Limited Company (HZNP)) has closed at $78.97, its traded Volume was 3234.14K shares, HZNP opened the Day at $78.13, it made an intraday Low of $76.96, and an intraday High of $79.8. HZNP (Horizon Therapeutics Public Limited Company (HZNP)) 52-week High is…
-
Stocks Ended Higher with Nasdaq Taking the Lead
U.S. stocks ended higher on Tuesday, with the Nasdaq posting back-to-back sessions of gains, as tech stocks continued to recover last week’s losses. The Dow Jones Industrial Average was up 2.27 points, or 0.01%, to 27,995.60. The S&P 500 gained 17.66 points, or 0.52%, to 3,401.20. The Nasdaq Composite rose 133.67 points, or 1.21%, to…
-
Stocks Opened Higher after Positive Economic Data from China
U.S.stocks opened higher on Tuesday, buoyed by positive economic news from China. The Dow Jones Industrial Average lately rose 207.32 points, or 0.74%, to 28,200.65. The S&P 500 advanced 32.16 points, or 0.95%, to 3,415.70. The Nasdaq Composite jumped 153.85 points, or 1.39%, to 11,210.50. Oil futures got a lift Tuesday as Hurricane Sally neared…
-
2020-09-14 Top Buy Stocks: AXTA, CSCO, CTL, LEN, PFE, WFC
NYSE: AXTA (Axalta Coating Systems Ltd. (AXTA)) NYSE: AXTA (Axalta Coating Systems Ltd. (AXTA)) has closed at $24.19, its traded Volume was 6050.92K shares, AXTA opened the Day at $23.17, it made an intraday Low of $23.04, and an intraday High of $24.4782. AXTA’s close price is above its Short term MA, short term MA…
-
2020-09-14 MACD(12, 26, 9) Bull Crossover Stocks: ALL, CSX, FIT, IAG, NI, OKE
NYSE: ALL (The Allstate Corporation (ALL)) NYSE: ALL (The Allstate Corporation (ALL)) has closed at $94.97, its traded Volume was 1076.6K shares, ALL opened the Day at $94.4, it made an intraday Low of $94.28, and an intraday High of $95.57. ALL (The Allstate Corporation (ALL)) 52-week High is $125.92, 52-week Low is: $64.13, it…
-
2020-09-14 MA5-MA15 Bull Crossover Stock: CROX, CSX, IMGN, PCG, SALM, SKX
NASDAQ: CROX (Crocs, Inc. (CROX)) NASDAQ: CROX (Crocs, Inc. (CROX)) has closed at $44.069, its traded Volume was 1522.73K shares, CROX opened the Day at $43.45, it made an intraday Low of $42.67, and an intraday High of $44.38. CROX (Crocs, Inc. (CROX)) 52-week High is $44.38, 52-week Low is: $8.4, it has supports at…
-
Stocks Ended Sharply Higher on Vaccine Hope, Merger News
U.S. stocks ended sharply higher on Monday, amid fresh hope for a coronavirus vaccine and a flurry of newly announced mergers and acquisitions among major companies. The Dow Jones Industrial Average rose 327.69 points, or 1.18%, to 27,993.33. The S&P 500 gained 42.57 points, or 1.27%, to 3,383.54. The Nasdaq Composite advanced 203.11 points, or…
-
Stocks Opened Higher as Vaccine, Merger News Drew Focus
U.S. stocks opened higher on Monday, as investors considered positive developments around a coronavirus vaccine candidate, and eyed a flurry of newly announced mergers and acquisitions among major companies. The Dow Jones Industrial Average lately rose 171.09 points, 0.62%, to 27,836.73. The S&P 500 added 31.13 points, or 0.93%, to 3,372.10. The Nasdaq Composite gained…
-
Stock in Focus: Immunogen Inc (IMGN)
Company Profile: ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; IMGN779 that is in Phase I clinical trial for the treatment…
Got any book recommendations?